Table 2

Lipid profile during the study period by treatment group, repeated measures and Bonferroni post hoc analysis, using last observation carried forward method for missing data
PJ Placebo P*** for PJ vs. placebo at 12 m
N Mean ± SD P for trend N Mean ± SD P for trend
LDL mg/dl 0 66 95.1 ± 31.5 0.07 35 95.8 ± 28.9 0.38 0.85
3 M 98.9 ± 35.6 98.0 ± 28.1
6 M 95.4 ± 32.4 91.8 ± 25.1
12 M 100.0 ± 33.1 94.3 ± 27.2 0.39
Total cholesterol mg/dl 0 66 164.8 ± 37.1 0.27 35 163.5 ± 33.4 0.18 0.86
3 M 167.7 ± 40.7 171.7 ± 35.1
6 M 163.4 ± 38.9 164.8 ± 38.0
12 M 167.3 ± 43.5 165.1 ± 35.8 0.79
HDL mg/dl 0 66 33.1 ± 9.5* <0.001 35 36.6 ± 10.7 0.18 0.10
3 M 37.2 ± 11.3 37.0 ± 11.7
6 M 36.6 ± 10.9 37.3 ± 12.9
12 M 36.8 ± 10.8 34.3 ± 15.4 0.40
HDL ≤40 mg/dl at study initiation 0 54 29.7 ± 5.7* <0.001 23 30.2 ± 5.6 0.09 0.84
3 M 33.8 ± 7.8 31.2 ± 7.6
6 M 33.6 ± 7.7 31.8 ± 10.2
12 M 33.6 ± 7.5 27.6 ± 11.6 0.03
TG mg/dl 0 66 183.6 ± 101.6** 0.05 35 176.7 ± 86.7 0.04 0.73
3 M 175.7 ± 90.8 192.9 ± 100.7
6 M 174.0 ± 89.8 193.6 ± 90.5
12 M 167.3 ± 86.3 206.1 ± 109.4 0.05
TG ≥200 mg/dl at study initiation 0 20 310.1 ± 87.8** 0.02 10 288.1 ± 71.9 0.15 0.13
3 M 267.3 ± 86.6 318.2 ± 96.6
6 M 248.7 ± 100.5 301.5 ± 78.2
12 M 237.4 ± 102.5 320.4 ± 56.8 0.008

*P < 0.05 for zero time vs. 3, 6 and 12 m; **P < 0.05 for zero time vs. 6 m and 12 m; ***T-test or Mann-whitny U test.

Shema-Didi et al.

Shema-Didi et al. Nutrition Journal 2014 13:18   doi:10.1186/1475-2891-13-18

Open Data